Ledger.Open graph →
SEC Form D · filed September 5, 2025

QurAlis Corp

Offering
$24.9M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Anne C. Whitaker · Cambridge, MADirectorKasper C. Roet · Cambridge, MAExec · Director · PromoterLuc C. Dochez · Cambridge, MADirectorAmy C. Schulman · Cambridge, MADirectorLaia C. Crespo-Martin · Cambridge, MADirectorJohannes C. Fruehauf · Cambridge, MADirectorMichael C. Hutton · Cambridge, MADirectorCillian C. King · Cambridge, MADirectorShafique C. Virani · Cambridge, MAExecMike Sodo · Salt Lake City, UTDirectorChristopher Kingsley · Lincoln, NEDirectorSebastian Milla · Lincoln, NEDirectorTim Warman · VANCOUVER, British Columbia, CanadaExec · Director · PromoterMatt Tucker · Salt Lake City, UTDirectorGino Zandonai · VANCOUVER, British Columbia, CanadaDirectorRobert M. Kennedy · Durham, NCDirectorJames C. Collins, Jr · Durham, NCDirectorJason C. Brown · Cambridge, MAExecSteven Estrick · Tampa, FLDirectorElyse M. Mclaughlin · Newark, NJDirectorKelly A. Coyne · Newark, NJDirectorAndrew R. French · Newark, NJDirectorPatrick E. Mcguinness · Newark, NJExec · Director · PromoterThomas M. Turpin · Newark, NJDirectorAndrew Rosen · Miami, FLDirectorDmitriy Azarenko · Miami, FLDirectorShafique C. Virani · Cambridge, MAExecJason C. Brown · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗